Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement.
This paper will evaluate various topics related to chemotherapy-induced nausea and vomiting. The results published reflect a consensus conference convened in Perugia, Italy. The topics discussed include antiemetic therapy of multiple-day chemotherapy, high-dose chemotherapy, and rescue antiemetics.
Einhorn
Lawrence H
LH
Division of Hematology-Oncology, Mel and Bren Simon Cancer Center, Indiana University, 535 Barnhill Room 473, Indianapolis, IN 46202-5289, USA. leinhorn@iupui.edu
Grunberg
Steven M
SM
Rapoport
Bernardo
B
Rittenberg
Cynthia
C
Feyer
Petra
P
D000932:Antiemetics / Q000008:administration & dosage* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003907:Dexamethasone / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D058831:Serotonin 5-HT3 Receptor Antagonists / Q000627:therapeutic use; D033581:Stem Cell Transplantation / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents; D058831:Serotonin 5-HT3 Receptor Antagonists; D003907:Dexamethasone